Cognitive Outcomes and Long-term Follow-up Results after Enhanced Chemotherapy Delivery for Primary Central Nervous System Lymphoma
- 1 January 2000
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 47, 51-61
- https://doi.org/10.1097/00006123-200001000-00010
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.Journal of Clinical Oncology, 1998
- Short Intensive Primary Chemotherapy and Radiotherapy in Sporadic Primary CNS Lymphoma (PCL)International Journal of Radiation Oncology*Biology*Physics, 1998
- Advances in the management of Hodgkinʼs and non-Hodgkinʼs lymphomaCurrent Opinion in Hematology, 1998
- Intravitreal Methotrexate as an Adjunctive Treatment of Intraocular LymphomaArchives of Ophthalmology (1950), 1997
- Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapyNeurology, 1996
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992
- Neuropsychological Assessment Outcomes of Nonacquired Immunodeficiency Syndrome Patients with Primary Central Nervous System Lymphoma before and after Blood-Brain Barrier Disruption ChemotherapyNeurosurgery, 1992
- Normative data on selected neuropsychological measures from a nonclinical sampleJournal of Clinical Psychology, 1985
- Radiation therapy in the management of primary malignant lymphoma of the brainInternational Journal of Radiation Oncology*Biology*Physics, 1981